| Literature DB >> 35648730 |
Aymery Constant1, Donaldson Conserve2, Karine Gallopel-Morvan1, Jocelyn Raude1.
Abstract
Background: During the COVID-19 crisis, protests against restrictions emerged and rule violations increased, provoking peaks in new positive cases, forcing authorities in France to impose fines to slow down the spread of the disease. Due to these challenges, subsequent implementations of preventive measures in response to COVID-19 recurrences or other pandemics could present difficulties for decision makers. A better understanding of the factors underlying the public acceptance of COVID-19 nonpharmaceutical preventive measures may therefore contribute greatly to the design of more effective public communication during future pandemics. Objective: The aim of this study was to evaluate the acceptance of COVID-19 nonpharmaceutical prevention measures in France. The specific objectives were (1) to examine the public's acceptance of COVID-19 nonpharmaceutical prevention measures and (2) to assess the association of the public's acceptance of these prevention measures and their perception of COVID-19.Entities:
Keywords: COVID-19; Extended Parallel Process Model; France; Likert scale; lockdown; nonpharmaceutical measures; public acceptance
Year: 2022 PMID: 35648730 PMCID: PMC9135098 DOI: 10.2196/32859
Source DB: PubMed Journal: JMIRx Med ISSN: 2563-6316
Participants’ characteristics (N=2004).
| Variables | Values | ||
|
| |||
|
| Male | 992 (49.5) | |
|
| Female | 1012 (50.5) | |
|
| |||
|
| ≥60 | 518 (25.8) | |
|
| 40-59 | 750 (37.1) | |
|
| 18-39 | 736 (36.7) | |
|
| |||
|
| Active | 1329 (66.3) | |
|
| Retired | 427 (21.3) | |
|
| Unemployed | 248 (12.4) | |
|
| |||
|
| ≥3 | 825 (41.2) | |
|
| 2 | 723 (36.1) | |
|
| 1 | 456 (22.8) | |
|
| |||
|
| Urban, more than 100,000 people | 385 (19.2) | |
|
| Urban, 20,000-100,000 people | 520 (25.9) | |
|
| Urban, 2000-20,000 people | 627 (31.3) | |
|
| Rural zone | 472 (23.6) | |
| Chronic disease, n (%) | 615 (30.7) | ||
|
| |||
|
| Poor/very poor | 208 (10.4) | |
|
| Good/very good | 1796 (89.6) | |
|
| |||
|
| Yes, related to COVID-19 | 404 (20.2) | |
|
| Yes, unrelated to COVID-19 | 480 (24) | |
|
| None | 1120 (55.9) | |
|
| |||
|
| Efficacy | 73.8 (17.4) | |
|
| Fear control | 54.5 (26) | |
|
| Severity | 73.5 (23.1) | |
|
| Vulnerability | 42.7 (22.4) | |
|
| Avoidance | 48.9 (22.9) | |
aEPPM: Extended Parallel Process Model.
Numbers, percentages, and factor loadings for the 2-factor solution of the acceptance of 8 nonpharmaceutical COVID-19 measures (N=2004).
| Item | Totally agree/agree, n (%) | Totally disagree/disagree, n (%) | Factors | |
|
|
|
| F1 | F2 |
| Make mask mandatory in public closed spaces | 1783 (89) | 221 (11) | N/Aa | 0.95 |
| Make mask mandatory in public open spaces | 1667 (83.2) | 337 (16.8) | N/A | 0.81 |
| Isolate vulnerable people (eg, older adults) | 1604 (80) | 400 (20) | 0.56 | N/A |
| Forbid mass gatherings (eg, fairs, markets) | 1590 (79.3) | 414 (20.7) | 0.59 | N/A |
| Mobility restrictions for nonessential workers | 1482 (74) | 522 (26) | 0.74 | N/A |
| Stay at home order for nonessential workers | 1314 (65.6) | 690 (34.4) | 0.85 | N/A |
| Close all schools/universities | 1286 (64.2) | 718 (35.8) | 0.80 | N/A |
| Close nonessential commerce (eg, bar, restaurant) | 1146 (57.2) | 858 (42.8) | 0.82 | N/A |
| Eigenvalue | N/A | N/A | 4.58 | 1.05 |
| Percentage of explained variance | N/A | N/A | 52.6 | 9.9 |
| Cronbach α | N/A | N/A | 0.88 | 0.87 |
aN/A: not applicable.
Respondents (N=2004) agreeing with proposed collective COVID-19 nonpharmaceutical prevention measures.
| Number of measures accepted | Respondents, n (%) |
| 0 | 122 (6.1) |
| 1 | 149 (7.4) |
| 2 | 186 (9.3) |
| 3 | 209 (10.4) |
| 4 | 239 (11.9) |
| 5 | 276 (13.8) |
| 6 | 823 (41.1) |
Rate ratios and 95% CIs of the acceptance of collective restrictions (N=2004), Poisson regression.a
| Variables | Univariate, rate ratio (95% CI) | Multivariateb, rate ratio (95% CI) | |||
|
| |||||
|
| Female | 1.03 (0.98-1.07) | N/Ac | ||
|
| Male | 1 | N/A | ||
|
| |||||
|
| ≥60 |
|
| ||
|
| 40-59 | 0.97 (0.92-1.02) | 0.96 (0.91-1.01) | ||
|
| 18-39 | 1 | 1 | ||
|
| |||||
|
| Active | 1.01 (0.94-1.07) | 1.02 (0.96-1.09) | ||
|
| Retired |
| 0.98 (0.88-1.09) | ||
|
| Unemployed | 1 | 1 | ||
|
| |||||
|
| Urban, more than 100,000 | 1.00 (0.94-1.07) | N/A | ||
|
| Urban, 20,000-100,000 | 1.04 (0.98-1.10) | N/A | ||
|
| Urban, 2000-20,000 | 1.04 (0.98-1.10) | N/A | ||
|
| Rural zone | 1 | N/A | ||
|
| |||||
|
| ≥3 |
| 1.04 (0.99-1.11) | ||
|
| 2 | 1.03 (0.97-1.09) | 1.03 (0.97-1.09) | ||
|
| 1 | 1 | 1 | ||
| Chronic disease | 1.00 (0.95-1.05) | N/A | |||
|
| |||||
|
| Poor/very poor | 0.96 (0.89-1.03) | N/A | ||
|
| Good/very good | 1 | N/A | ||
|
| |||||
|
| Yes, related to covid | 1.07 (1.02-1.13) | N/A | ||
|
| Yes, unrelated to covid | 1.01 (0.96-1.07) | N/A | ||
|
| None | 1 | N/A | ||
|
| |||||
|
| Efficacy |
|
| ||
|
| Lack of fear control |
|
| ||
|
| Severity |
|
| ||
|
| Vulnerability |
| 1.01 (0.99-1.02) | ||
|
| Avoidance |
| 1.00 (0.99-1.02) | ||
aSignificant results (P<.05) are marked in italics.
bGoodness of fit for the multivariate model (value/df for the deviance)=1.08.
cN/A: not applicable.
dEPPM: Extended Parallel Process Model.
Rate ratios and 95% CIs of the acceptance of individual protective measures (N=2004), Poisson regression.a
| Variables | Univariate, rate ratio (95% CI) | Multivariateb, rate ratio (95% CI) | |||
|
| |||||
|
| Female | 1.04 (0.97-1.11) | N/Ac | ||
|
| Male | 1 | N/A | ||
|
| |||||
|
| ≥60 | 1.08 (0.99-1.17) | N/A | ||
|
| 40-59 | 1.04 (0.96-1.12) | N/A | ||
|
| 18-39 | 1 | N/A | ||
|
| |||||
|
| Active | 1.02 (0.92-1.13) | N/A | ||
|
| Retired | 1.09 (0.97-1.23) | N/A | ||
|
| Unemployed | 1 | N/A | ||
|
| |||||
|
| Urban, more than 100,000 people | 0.95 (0.86-1.06) | N/A | ||
|
| Urban, 20,000-100,000 people | 0.99 (0.90-1.09) | N/A | ||
|
| Urban, 2000-20,000 people | 1.01 (0.92-1.10) | N/A | ||
|
| Rural zone | 1 | N/A | ||
|
| |||||
|
| ≥3 | 1.04 (0.95-1.14) | N/A | ||
|
| 2 | 1.04 (0.95-1.14) | N/A | ||
|
| 1 | 1 | N/A | ||
| Chronic disease | 1.07 (0.99-1.15) | N/A | |||
|
| |||||
|
| Poor/very poor | 0.96 (0.86-1.07) | N/A | ||
|
| Good/very good | 1 | N/A | ||
|
| |||||
|
| Yes, related to covid | 0.98 (0.90-1.07) | N/A | ||
|
| Yes, unrelated to covid | 1.01 (0.963-1.09) | N/A | ||
|
| None | 1 | N/A | ||
|
| |||||
|
| Efficacy |
|
| ||
|
| Lack of fear control |
|
| ||
|
| Severity |
|
| ||
|
| Vulnerability |
| 1.00 (0.98-1.02) | ||
|
| Avoidance | 1.00 (0.98-1.02) | N/A | ||
aSignificant results are marked in italics.
bGoodness of fit for the multivariate model (value/df for the deviance)=0.34.
cN/A: not applicable.
dEPPM: Extended Parallel Process Model.